Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A voluntary safety recall of widely used Alaris infusion ...

Baxter ($BAX) is facing a new set of regulator entanglements related to the infusion pumps that were yanked from the market two years ago because manufacturing issues ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced a new initiative to address safety problems associated with external infusion pumps and is ...

The use of smart pump technology has been proven to reduce the frequency of errors in the administration of intravenous drugs. But software glitches and other potentially dangerous problems persist.

Add Yahoo as a preferred source to see more of our stories on Google. Fresenius Kabi recalled some of its large volume infusion pumps over a software problem that can lead to delays or interruptions ...

An unspecified number of ambulatory infusion pumps were recalled because of nearly 3,700 complaints related to several product issues, the FDA said March 20. InfuTronix voluntarily recalled five types ...

Smiths Medical has been urging healthcare providers to update tens of thousands of its hospital syringe pumps after identifying issues with outdated software, and now the FDA is helping to get the ...

Hospira ($HSP) now faces a Class I recall--the FDA's most serious--because of malfunctioning problems with the company's Symbiq infusion pump system. The designation ...

Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.